Companies such as Abbott (U.S.), Boston Scientific Corporation (U.S.), ACIST Medical Systems (U.S.), Koninklijke Philips N.V. (Netherlands), Opsens (Canada), Heartflow, Inc. (U.S.) and among others are the major companies in the fractional flow reserve market.
In October 2023, Philips revealed that Instantaneous Wave-Free Ratio (IFR) and Fractional Flow Reserve (FFR) are equally safe and effective for diagnosing heart disease, offering healthcare providers more flexibility and reducing the need for invasive procedures. In November 2024, Boston Scientific launched Avvigo, a multi-functional imaging system for cardiovascular procedures. It provides real-time, high-definition imaging, improving accuracy, reducing complications, and enhancing patient outcomes while streamlining workflows in cardiovascular care.
The countries covered in the fractional flow reserve market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.